"We have CHR initiating a quarterly dividend of $0.06/share"CIBC is out with a note on CHR, boosting target price to $3.50 from $3.25.
They see 2025 EPS at 33-cents from 25-cents.
They also highlight $250m in liquidity. If they can get an 11% return on that, it would add $26m in annual EBITDA but management better really nail some deals if it's going that route. I'd much rather see $100m dedicated to an SIB, which could take out around 15-18% of shares and would be accretive.